Literature DB >> 7978284

Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3.

Q M Wang1, P J Roach, C J Fiol.   

Abstract

Glycogen synthase kinase 3 (GSK-3) is involved in the regulation of several metabolic enzymes and transcription factors in response to extracellular signals. Here we report the use of a synthetic peptide derived from the sequence of the cyclic AMP responsive element binding protein (CREB) as a specific substrate for GSK-3 isoforms. The 13-amino acid peptide, KRREILSRRPSYR, was phosphorylated by the catalytic subunit of cAMP-dependent protein kinase (PKA) and purified on a C18 cartridge. Phosphorylation of the COOH-terminal serine of the peptide by PKA creates a phosphorylation site for GSK-3 since GSK-3 recognizes the consensus motif -S-X-X-X-S(P)-. Although the COOH-terminal serine of the peptide can be phosphorylated by PKA and several other kinases, the phospho-CREB peptide is specific for GSK-3 with Kms of 140 and 200 microM for GSK-3 alpha and GSK-3 beta isoforms, respectively. Using the phospho-CREB peptide, we have successfully purified GSK-3 activity from rabbit skeletal muscle and Escherichia coli cells transformed with a GSK-3 expression vector. The assay described provides a convenient and specific determination of GSK-3 activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7978284     DOI: 10.1006/abio.1994.1356

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

1.  Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.

Authors:  Gerardo Morfini; Györgyi Szebenyi; Ravindhra Elluru; Nancy Ratner; Scott T Brady
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

2.  The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.

Authors:  Nichole E LaPointe; Gerardo Morfini; Gustavo Pigino; Irina N Gaisina; Alan P Kozikowski; Lester I Binder; Scott T Brady
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

3.  Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells.

Authors:  H Eldar-Finkelman; G M Argast; O Foord; E H Fischer; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

4.  Overexpression of GSK3betaS9A resulted in tau hyperphosphorylation and morphology reminiscent of pretangle-like neurons in the brain of PDGSK3beta transgenic mice.

Authors:  Baolin Li; John Ryder; Yuan Su; Steven A Moore; Feng Liu; Patricia Solenberg; Kellie Brune; Niles Fox; Binhui Ni; Rugao Liu; Yan Zhou
Journal:  Transgenic Res       Date:  2004-08       Impact factor: 2.788

5.  Class I PI3K Biology.

Authors:  Tihitina Y Aytenfisu; Hannah M Campbell; Mayukh Chakrabarti; L Mario Amzel; Sandra B Gabelli
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

6.  Functional studies of shaggy/glycogen synthase kinase 3 phosphorylation sites in Drosophila melanogaster.

Authors:  Deppie Papadopoulou; Michele Wolfe Bianchi; Marc Bourouis
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

7.  A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons.

Authors:  Gerardo Morfini; Györgyi Szebenyi; Hannah Brown; Harish C Pant; Gustavo Pigino; Scott DeBoer; Uwe Beffert; Scott T Brady
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

Review 8.  Enzyme Activity Assays for Protein Kinases: Strategies to Identify Active Substrates.

Authors:  Brad A Haubrich; David C Swinney
Journal:  Curr Drug Discov Technol       Date:  2016

9.  Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome.

Authors:  Marjelo A Mines; Richard S Jope
Journal:  Front Mol Neurosci       Date:  2011-11-01       Impact factor: 5.639

10.  A novel mass spectrometry-based assay for GSK-3beta activity.

Authors:  Erin Bowley; Erin Mulvihill; Jeffrey C Howard; Brian J Pak; Bing Siang Gan; David B O'Gorman
Journal:  BMC Biochem       Date:  2005-12-16       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.